洞察
Insights From Our Experts
Articles
Pharma USA Webinar: Hot For Hybrid: Building Medical Field Teams For Healthcare’s New Normal
Posted on 6月 11, 20216/11/21
Hot For Hybrid: Building Medical Field Teams For Healthcare’s New Normal Featuring EVERSANA’s Marc Bernarducci, Senior Vice President of Field Solutions — Clinical This panel covers the following topics: Review the implications of new field force…
3 Ways Field Teams Can Shape the Market Before and After Product Launch
Posted on 5月 26, 20215/26/21
“It is not how much you have or know, or even who you know; it is how well you adapt to the inevitable changes along the way. As Heraclitus, the Greek philosopher, said, ‘Change is the…
Visualizing EVERSANA’s Omnichannel Activation Model
The pharma industry’s needs have evolved beyond one-dimensional playbooks, disconnected promotional efforts and limited ability to assess stakeholder engagement. Manufacturers need to adopt an omnichannel model that goes beyond “marketing” to provide actionable insights that better…
Expect More From Your Omnichannel Strategy and Investments
From ordering your daily Starbucks latte on your iPhone to skipping the line at Splash Mountain with your Disney Magic Band, omnichannel strategies transform how consumers interact with their favorite brands. The most successful brands create…
How to Scale Your Learning & Development Department: Ask The Expert
For years, Learning and Development teams have been asked to “do more with less.” When budgets tightened, teams would get more creative allocating their resources and time. But today – in the midst of changing market…
Reinventing Launch: The Gold Standard Of Drug Commercialization
In a world that is rapidly changing, we must evolve beyond traditional strategies to create true impact for patients. EVERSANA's complete end-to-end commercialization model enables manufacturers to bring their drug to market at a fraction of…
How to Enhance Provider and Patient Engagement in Tech-Savvy Healthcare
Pharmaceutical representatives have always been a welcomed resource and consistent office visitor for healthcare providers (HCPs). Today, in a world operating largely virtually, pharma reps are re-strategizing HCP engagement in the same way providers are rethinking…
PharmaVOICE100 Recognizes Two EVERSANA Leaders
For the past 15 years, PharmaVOICE has celebrated leaders throughout the life sciences industry who provide inspiration to their peers, colleagues and companies through their innovative and motivational approaches to addressing the industry’s myriad challenges. As…
The New Gold Standard of Drug Commercialization
Manufacturers spend >$125MM over three years leading up to launch, yet 66% of drugs don’t meet launch expectations. An unpredictable landscape, coupled with inevitable industry pressures, is forcing manufacturers to seek a more complete commercialization approach…
How to Demonstrate Value to Providers, Payers & Patients
Fact: Primary stakeholders – providers, patients and payers – have greater expectations than ever before. To ensure success at every stage of the product life cycle, it’s imperative to deploy a sophisticated, clinically oriented and data-driven…